medigraphic.com

2011, Número 3

<< Anterior Siguiente >>

Anales de Radiología México 2011; 10 (3)


Indicaciones y experiencia en crioablación

Viramontes TG

Idioma: Español
Referencias bibliográficas: 42
Paginas: 140-145
Archivo PDF: 244.69 Kb.


RESUMEN

El enfriamiento como parte del tratamiento de algunas afecciones es muy antiguo. El uso del frío extremo para el tratamiento de tumores de manera percutánea se practica desde hace dos décadas, tras el desarrollo de agujas de menor calibre que permitieron su colocación con menos riesgos.
La crioablación permite el tratamiento de tumores localizados en pulmón, mediastino, hueso, hígado, riñón, próstata y mama. Estos tratamientos pueden ser curativos o paliativos. La crioablación percutánea ofrece ventajas tales como: margen ablativo predecible y observable en tomografía computada, tratamiento prácticamente ambulatorio, efecto analgésico, desarrollo de respuesta inmunitaria. Se recomienda para pacientes ancianos o que por sus enfermedades impliquen altos riesgos si son sometidos a intervenciones quirúrgicas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Goldeberg et al. Image-guided tumor ablation: Standardization of Terminology and Reporting criteria. J Vasc Radiol 2009; 20:377-390.

  2. Gage AA. History of cryosurgery. Smin Surg Oncol 1998;14;99-109.

  3. Cooper SM, Dawber RP. The history of cryosurgery. J R Soc Med 2001;94:196-201.

  4. Cooper IS, A new method of destruction of extirpation of benigno r malignant tissues. N Eng J med 1963;263:741-749.

  5. Fortner JG, Blumgart LH. A historic perspective of liver surgery for tumors at the end of the millennium. J Am Coll Surg 2001;193:210-222.

  6. Rewcastle JC, Sandison GA, Saliken JC Donnelly BJ et al. Consideration durin clinical operation of two commerciall available cryomachines. J Surg Oncol 1999;71;106-111.

  7. Lee DI, McGinnins DE, Feld R, Strup SE. Retroperitoneal laparoscopic cryoablation of small renal tumors: intermédiate results. Urology 2003:61:83-88.

  8. Gage A. Baus JM, Baus JGExperimental cryosurgery Investigations In Vivo. Cryobology 2009; 59:229.

  9. Ahmed A, Littrup P. Percutaneous Cryotherapy of the Thorax: Safety Considerations for Complex Cases. AJR 2006; 186: 1703-06.

  10. Hongwu W, Littrup P, Yunyou D. Thoracic Masses Treated with percutaneous Cryotherapy: Initial Experience with More tan 200 Procedures. Radiology 2005;235:289-298.

  11. Maiwand, M.O. Asimakopoulos G. Cryosurgery for Lung Cancer: Clinical Results and Technical Aspects. Tech in Cancer Res & T. 2004 2:144-150.

  12. Masafumi K, Yotaro I, Norimasa T. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J. Thorac Cardiovasc Surg 2006;131:1007-1013.

  13. Percutaneos cryoablation of Small Hepatocellular Carcinoma with US Guidance and CT Monitoring: Initial Experience. Orlacchio A, Bazzocchi G, Pastorelli D. Cardiovasc Intervent Radiol 2008; 31:587-594.

  14. Cliff R. Davis M. Interventional RAdiological Treatment of Hepatocellular Carcinoma. Cancer Control. April 2010; 17: 87-99.

  15. Ablative Technologies in the Management of Patients with Primary and Secondarya Liver Cancer: An Overview. Can As of Rad J 2010; 61: 217-222.

  16. Meyers M, Sasson A, Sigurdson E. Locoregional Strategies for Colorectal Hepatic Metastases. Clinical Colorectal Cancer 2003; 3: 34-44.

  17. Outcomes of a single-centre experience of hepatic resection and cryoablation of sarcoma liver metastes. Terence C, Chu, francis F. Am J Clin Oncol 2011; 34: 317-320.

  18. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23: 109-113. Discussion 113-114.

  19. Bageaucu S, Kaczmarek D, Lacroix M et al. Cryosurgery of resectable and unresectable hepatic metastases from colorectal cancer. Eur J Surg Oncol 2007;33: 590-596.

  20. Seifert JK, France MP, Zhao J et al. Large volumen hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 2002; 26: 1333-1341.

  21. Kunkle D, Uzzo Robert. Cryoablation or radiofrequency Ablation of the small Renal Mass: A Meta-analysis. Cancer 2008; 113: 2671-2680.

  22. Uppot R, Silverman S, Zagoria R. Imaging-Guided Percutaneous Ablation of renal cell Carcinoma: a primer of how we do it. AJR 2009; 192: 1558-1570.

  23. Nurko J, Mabry C, Whitworth P et al. Interim results from the FibroAdenoma Cryoablation Treatment Registry. Am J Surg 2005; 190: 647-652.

  24. Nikolai N. Gerhard H. Breast Cancer Crysurgery. 13th World Congress of the International Society of Cryosurgery Crete, Greece May 2005; 69-70.

  25. Bland K, Gass J, Klimberg V. Radiofrequency, cryoablation, and other modalities for breast cáncer ablation. Surg Clin North Am 2007; 87: 539-50.

  26. Pusceddu C, Capobianco G, Meloni F. CTguided cryoablation of both breast cancer and lymph node axilary metástasis. Eur J Gynaecol Oncol 2011; 32: 224-5.

  27. Callstrom MR, Atwell Td, Charonueau JW et al. Painful metastases involving bone: percutaneous imagen-guided cryoablation-prospective trial interime analyysis. Radiology 2006; 241:572.

  28. Callstro M, Kurup N. Percutaneous ablation for bone and soft tissue metastases-why cryoablation? Skeletal Radiol 2009; 38: 835-839.

  29. Gangi A, Tsoumakidou G, Buy X. Quality improvement guidelines for bone tumour management. Cardiovasc Intervent Radiol 2010; 33: 706-713.

  30. Society of Interventional Radiology: Shutting Out Soft Tissue Cancer in the Cold. Littrup P. Managed Care Weekly Dig 2010; 29: 125.

  31. Anderson P, Kornguth D, Ahrar K. Recrrent, refractory, metastatic and/or unresectable pediatric sarcomas: treatment options for younf people “off the roadmap”. Pediatric Health 2008; 2: 605-615.

  32. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Kujak J, Liu P, Johnson G. Skeletal Radiol 2010;39:175-182.

  33. Onike C. Image-Guided Prostate Cryosurgery: State of the Art. Cancer Control. November/December 2001; 8: 522-531.

  34. Chin J, Darwin F, Abdelhady M. Review of Primary and Salvage Cryoablation for Prostate Cancer. Cancer Control 2007; 14: 231-237.

  35. Tumor cryoablation combined with palliative bypass surgery in the treatment of unresectble pancreatic cancer: a retrospective study of 142 patients. Jingdong L, Xiaoli C. Hanfeng Y. Postgrad med J Feb 2011;87: 89-95.

  36. Chiu D, Niu L, Mu F, et al. The experimental study for efficacy and safety of pancreatic cryosurgery. Cryobiology 2010; 60: 281-6.

  37. Chen XL, Ma Y, Wan Y et al. Experimental study of the safety of pancreas cryosurgery: comparison of 2 different techniques of cryosurgery. Pancreas 2010; 39:92-6.

  38. Li C, Wu L, Song J. MR imaging-guided cryoablatio of metastastic brain tumors: initial experience in six patients. Eur Radiol 2010; 20:404-9.

  39. Thermal Protection During Percutaneous Thermal Ablation Procedures: Interest of Carbon Dioxide Dissection and Temperature Monitoring. Buy X, Tok C, Szware G. Cardiovasc Intervent Radiol 2009;32:529-534.

  40. Satomi K, Solomon S, Bluemke D. CT and MR Imaging Appearence of Renal Neoplasmas after Radiofrequency Ablation and Cryablation. Semin Ultrasound CT MR 2009; 30: 67-77.

  41. Theodorescu D. Cancer cryotherapy: evolution and biology. Rev Uro 2004;6 Suppl 4:S9-S19.

  42. Sung GT, Gill IS, Hsu TH et al: Efect of intentional cryo-injury to the renal collecting system. J Urol. 2003;170: 619-622.




2020     |     www.medigraphic.com